. 2013 Apr 8;6:123–129. doi: 10.2147/DMSO.S42729

Table 2.

Predictors of the glycemic target (HbA_1c ≤ 7%) in the overall population, as well as in males and females

	Males OR (95% CI)	Females OR (95% CI)	Overall OR (95% CI)
Diabetes duration	0.864 (0.800–0.932)^a	0.998 (0.947–1.051)	0.942 (0.904–0.982)^a
Baseline BMI	1.049 (0.977–1.1126)	1.003 (0.946–1.063)	1.013 (0.970–1.057)
Baseline HbA_1c	0.520 (0.354–0.764)^a	0.691 (0.462–1.033)	0.646 (0.498–0.839)^a
Therapy^*	1.458 (0.656–3.240)	0.321 (0.148–0.696)^a	0.596 (0.352–1.007)
HOMA-B^**	0.799 (0.529–1.208)	1.668 (1.071–2.599)^a	1.679 (0.993–2.838)

Notes: Results are expressed as OR (95% CI) after a logistics regression model where the dependent variable was target outcome “y” (yes = 1; no = 0), and age, duration of diabetes, baseline HbA_1c, background antidiabetic therapy, and baseline BMI were the independent variables.

Therapy was categorized as metformin = 0; sulphonylureas or associations = 1;

^**

carried out in 117 individuals (61 males/56 females).

statistically significant.

Abbreviations: HbA_1c, hemoglobin A_1c; OR, odds ratio; CI, confidence interval; BMI, body mass index; HOMA-B, homeostasis model assessment-B.